Ischemia Research and Education Foundation did the independent, well documented
study that determined Trasylol's life threatening risks and excessively high costs
and that at least 10,000 patients were on dialysis caused by aprotinin
injection. Read more...
Personal Injury Disclaimer: This website provides general information about Pennsylvania Trasylol lawsuits and other legal information. Nothing on this site is intended to be legal advice. The materials on this site may be considered advertising. Nothing on this site constitutes the formation of an attorney client relationship. This website is not intended to solicit clients outside the Commonwealth of Pennsylvania. In order to discuss representation, we must personally speak with you and enter into a signed, written agreement for representation. By utilizing this site, you agree to the foregoing.